Common Contracts
3 similar Common Stock Purchase Warrant contracts by NKGen Biotech, Inc.
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Common Stock Purchase Warrant • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $220,000.00 to the Holder (as defined below) of even date) (the “Note”), Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC (including any permitted and registered assigns, collectively, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 220,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Common Stock Purchase Warrant • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $330,000.00 to the Holder (as defined below) of even date) (the “Note”), AJB CAPITAL INVESTMENTS LLC (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 330,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 9, 2024, by and among the Company and the Holder (the “Purchase Agree
COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Common Stock Purchase Warrant • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Nevis
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured zero coupon promissory note in the principal amount of $616,000.00 to the Holder (as defined below) of even date) (the “Note”), GENERATING ALPHA LTD (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 550,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated May 7, 2024, by and among the Company and the Holder (the “Purchase
